Clinical Trial Update: Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 long-term follow-up study of mesenchymal stem cell therapy for virus-related liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Ukraine Association of Biobank | Conditions: Liver Cirrhosis | Phase 3 | Status: COMPLETED